FibroGen Inc FGEN

NAS: FGEN | ISIN: US31572Q8087   8/07/2025
5,620 USD (+4,66%)
(+4,66%)   8/07/2025
Grafiek FibroGen Inc Grafiek FibroGen Inc

FibroGen Inc in het nieuws

6 augustus 2022 · FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN · Persbericht

14 mei 2022 · FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of FibroGen, Inc. - FGEN · Persbericht

20 augustus 2021 · Astellas Receives European Commission Approval for First-in-Class EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease · Persbericht

25 juni 2021 · Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease · Persbericht

11 juni 2021 · FIBROGEN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against FibroGen, Inc. - FGEN · Persbericht

7 juni 2021 · Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against FibroGen, Inc. · Persbericht

2 juni 2021 · Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. · Persbericht

28 mei 2021 · Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against FibroGen Inc. (FGEN) · Persbericht

26 mei 2021 · Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. (FGEN) · Persbericht

21 mei 2021 · DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in FibroGen, Inc. Securities Fraud Class Action Lawsuit · Persbericht

Profiel FibroGen Inc

Biotechnologie
Fabricage van farmaceutische preparaten
Gezondheidstechnologie
Productie

Website: www.fibrogen.com

Hoofdzetel: San Francisco, California vlag Verenigde Staten

CEO: Enrique Conterno

Werknemers: 466

Mijn selecties